Search results
Current and investigational treatments for sarcoidosis based on pathogenesis. Treatments for sarcoidosis target antigen presentation, T cell activation, cytokine/chemokine profiles, propagation of granulomatous inflammation, T-regulatory balance, and the fibrotic response.
- Current and emerging pharmacological treatments for sarcoidosis: a ...
A Delphi study of sarcoidosis experts reached a consensus...
- Clinical Pharmacology in Sarcoidosis: How to Use and Monitor ...
We discuss the mechanism of action, dosing, side-effect...
- ERS clinical practice guidelines on treatment of sarcoidosis
Background: The major reasons to treat sarcoidosis are to...
- Current and emerging pharmacological treatments for sarcoidosis: a ...
A Delphi study of sarcoidosis experts reached a consensus that corticosteroids are the drug of choice for pulmonary sarcoidosis.13 The ATS/ERS/WASOG consensus recommends a daily prednisone equivalent of 20–40 mg for the initial treatment of pulmonary sarcoidosis.
8 wrz 2021 · A consensus statement from sarcoidosis experts endorses glucocorticoids as the primary treatment for sarcoidosis, on the basis of their efficacy and ease of use (low cost and oral administration...
30 sty 2019 · These powerful anti-inflammatory drugs are usually the first line treatment for sarcoidosis. In some cases, corticosteroids can be applied directly to an affected area — via a cream to a skin lesion or drops to the eyes.
We discuss the mechanism of action, dosing, side-effect profile, approach to monitoring and patient counselling concerning glucocorticoids, and the common alternative drugs recommended for use in the recent European Respiratory Society (Lausanne, Switzerland) Sarcoidosis Treatment Guidelines.
16 gru 2021 · Background: The major reasons to treat sarcoidosis are to lower the morbidity and mortality risk or to improve quality of life (QoL). The indication for treatment varies depending on which manifestation is the cause of symptoms: lungs, heart, brain, skin or other manifestations.
17 sie 2022 · Current advancements in personalized and precision medicine as well as the introduction of compounds developed specifically for sarcoidosis treatment, underscore the imperative of standardized elements of clinical trial design in either collective or organ-specific sarcoidosis.
